✦ LIBER ✦

110Phase II study of denileukin diftitox (Ontak) in the treatement of steroid resistant acute graft versus host disease (AGVHD)

✍ Scribed by P. Shaughnessy; C. Bachier; M. Grimley; C.F. LeMaistre

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Denileukin diftitox for the treatment of

✍ Paul J. Shaughnessy; Carlos Bachier; Michael Grimley; Cesar O. Freytes; Natalie 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 108 KB

384: Daclizumab and Infliximab for Treat

✍ R.L. Snyder; C. Daum; E. Klinger; S. Neudorf; L. Simpson 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Mesenchymal stem cells for treatment of

✍ Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roel 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 169 KB

306: Successful phase II trial using mes

✍ P. Kebriaei; L. Isola; E. Bahceci; H.K. Holland; S. Rowley; J. McGuirk; M. Devet 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Phase-1 study of siplizumab in the treat

✍ Joel A. Brochstein; Stephan Grupp; Harry Yang; Stanley R. Pillemer; Gregory P. G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

Preliminary Results From a Single Instit

✍ Khandelwal, Pooja; Filipovich, Alexandra; Davies, Stella; Jordan, Michael; Blees 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 82 KB